A detailed history of Engineers Gate Manager LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 26,450 shares of AMPH stock, worth $1.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,450
Previous 35,695 25.9%
Holding current value
$1.2 Million
Previous $1.43 Million 10.09%
% of portfolio
0.03%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.99 - $50.09 $341,972 - $463,082
-9,245 Reduced 25.9%
26,450 $1.28 Million
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $396,162 - $445,669
10,250 Added 40.28%
35,695 $1.43 Million
Q1 2024

May 15, 2024

BUY
$42.85 - $63.45 $616,654 - $913,108
14,391 Added 130.19%
25,445 $1.12 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $284,380 - $402,248
6,392 Added 137.11%
11,054 $683,000
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $212,167 - $303,030
4,662 New
4,662 $214,000
Q1 2023

May 15, 2023

SELL
$27.99 - $37.92 $96,481 - $130,710
-3,447 Reduced 21.18%
12,826 $480,000
Q4 2022

Feb 14, 2023

BUY
$27.93 - $31.27 $454,504 - $508,856
16,273 New
16,273 $455,000
Q1 2022

May 16, 2022

SELL
$22.96 - $36.45 $415,438 - $659,526
-18,094 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$18.14 - $23.29 $328,225 - $421,409
18,094 New
18,094 $421,000
Q3 2021

Nov 15, 2021

SELL
$17.83 - $21.49 $306,390 - $369,284
-17,184 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$17.11 - $20.92 $85,310 - $104,307
-4,986 Reduced 22.49%
17,184 $346,000
Q1 2021

May 17, 2021

SELL
$17.21 - $20.65 $135,012 - $161,999
-7,845 Reduced 26.14%
22,170 $406,000
Q4 2020

Feb 16, 2021

BUY
$17.76 - $21.24 $8,187 - $9,791
461 Added 1.56%
30,015 $604,000
Q3 2020

Nov 16, 2020

SELL
$17.99 - $22.22 $405,566 - $500,927
-22,544 Reduced 43.27%
29,554 $554,000
Q2 2020

Aug 17, 2020

BUY
$14.25 - $22.46 $400,296 - $630,923
28,091 Added 117.01%
52,098 $1.17 Million
Q1 2020

May 15, 2020

BUY
$12.66 - $20.08 $303,928 - $482,060
24,007 New
24,007 $356,000
Q3 2018

Nov 01, 2018

SELL
$15.39 - $19.38 $389,874 - $490,953
-25,333 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$14.63 - $19.6 $370,621 - $496,526
25,333 New
25,333 $387,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.22B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.